Streetwise Nutraceuticals Articles


Yields Over 9% and Discounts Up to 22% Make for Buys

Contributed Opinion
  ()
Money manager Adrian Day looks at several non-resource companies in his portfolio, most with very attractive dividend yields as high as more than 9%. read more >

Three Small-Caps on This Fund Manager's List

  ()
Steve Palmer, founding partner, President and Chief Investment Officer of AlphaNorth Asset Management, talks with Streetwise Reports about several small-cap companies from three sectors that he has been following. read more >

Update on Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed

Contributed Opinion
  ()
Technical analyst Clive Maund provides an update on a company whose product is replacing antibiotics for growth promotion in animal feed. read more >

This Biotech, Whose Discovery Could End Routine Antibiotic Use in Livestock, Is the Pick of Three Fund Managers

  ()
Multiple governments around the world have unleashed mandates on livestock feed regulations that pose an opportunity for a Canada-based biotech company. read more >
News Update

Animal Health Product Developer to Expand Sales Footprint

News Update
  ()
This Canadian company makes progress with its commercial uptake efforts. read more >

Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed

Contributed Opinion
  ()
As the worldwide movement to ban antibiotics as a growth promoter in animal feed gains traction, technical analyst Clive Maund has called an "immediate strong buy" on a company that has developed an alternative. read more >
News Update

Life Sciences Company Hits Sales Milestone with Livestock Product

News Update
  ()
With this development, the Canadian firm entered a new geography and an additional market segment. read more >
News Update

Life Science Company Sells Large Order of Non-Antibiotic Growth Promoter for Livestock

News Update
  ()
This is the second large shipment to the Philippine distributor. read more >
Showing Results: 1 to 8 of 8

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts